Page last updated: 2024-11-05

methylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

methyl group : An alkyl group that is the univalent group derived from methane by removal of a hydrogen atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6329
CHEMBL ID43280
CHEBI ID16830
MeSH IDM0089238

Synonyms (104)

Synonym
AKOS009031510
methyl-amine
monomethylamine
CHEBI:16830 ,
methyl group
aminomethane
menh2
ch3-nh2
mercurialin
carbinamine
NME ,
inchi=1/ch5n/c1-2/h2h2,1h
einecs 200-820-0
un1235
hsdb 810
ccris 2508
methylaminen [dutch]
metyloamina [polish]
un1061
metilamine [italian]
anhydrous methylamine
ai3-15637-x
n-methylamine
methylamine ,
methanamine
C00218
74-89-5
jandajel(tm)-nh2, 100-200 mesh, extent of labeling: 1.0 mmol/g n loading, 2 % cross-linked
jandajel(tm)-nh2, 50-100 mesh, extent of labeling: 1.0 mmol/g n loading, 2 % cross-linked
jandajel(tm)-nh2, 200-400 mesh, extent of labeling: 1.0 mmol/g n loading, 2 % cross-linked
DB01828
methylamine, anhydrous, >=98%
monomethylammonium ion
CHEMBL43280
M0137
M1016
methylamine bisulfite
STL281863
bdbm50416492
integrase inhibitor, r3{3}
bsf23sj79e ,
metyloamina
methylamine, anhydrous
methylaminen
unii-bsf23sj79e
methylamine, anhydrous [un1061] [flammable gas]
ec 200-820-0
metilamine
FT-0628859
methylamine [hsdb]
gadodiamide hydrate impurity c [ep impurity]
methylamine [mi]
BP-11399B
methylamine (anhydrous)
n-methyl amine
monomethyl amine
methylarnine
methlyamine
nh2ch3
methaneamine
methylamine-
methyl amine
methlamine
metylamine
methylammonia
h2nch3
ch3nh2
mono-methyl amine
methylamin
mono-methylamine
methyamine
h2nme
mono methyl amine
nh2me
un 1061
un 1235 (salt/mix)
3p8 ,
M2324
M2108
M2323
mfcd00008104
DTXSID7025683 ,
methylamine, 2m in methanol
methylamine, 2m in tetrahydrofuran
methylamine, purum, >99.5%
methylamine, purum, >=99.0%
methylamine, >=99.0%
methyl of gamma-n-methylasparagine
methylamine anhydrous
methylamine aq
M3340
Q409304
STR00032
BCP31897
methanamine-d2;methyl(2h2)amine
methylamine, 33% in ethanol
methylamine, ca. 2 m in ethanol
M3341
methylamine (ca. 7% in n,n-dimethylformamide, ca. 2.0mol/l)
methylamine (ca. 9% in acetonitrile)
metilamino
gadodiamide hydrate impurity c (ep impurity)
methylamine, (anhydrous)
dtxcid305683

Research Excerpts

Overview

Methylamine is an endogenous aliphatic amine exhibiting anorexigenic properties in mice. It is a product of adrenaline catalyzed by type A monoamine oxidase (MAO-A)

ExcerptReferenceRelevance
"Monomethylamine (MMA) is an important climate-active oceanic trace gas and ubiquitous in the oceans. "( Crystal structures of γ-glutamylmethylamide synthetase provide insight into bacterial metabolism of oceanic monomethylamine.
Chen, XL; Chen, Y; Gao, C; Li, CY; Li, F; Li, S; Peng, M; Shen, QT; Wang, N; Wang, P; Yang, GP; Zhang, N; Zhang, YZ,
)
0.9
"Methylamine is an endogenous aliphatic amine exhibiting anorexigenic properties in mice. "( Methylamine-dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats.
Alfarano, C; DeSiena, G; Ghelardini, C; Livi, S; Pacini, A; Pirisino, R; Raimondi, L, 2007
)
3.23
"Methylamine was confirmed to be a product of adrenaline catalyzed by type A monoamine oxidase (MAO-A)."( Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy.
Lai, CT; Yu, PH; Zuo, DM, 1997
)
1.02
"Methylamine is a constituent of cigarette smoke and the major end product of nicotine metabolism. "( Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.
Yu, PH, 1998
)
2.05
"Methylamine sensitivity is an order of magnitude greater."( A rapid, sensitive high-performance liquid chromatography analysis of ammonia and methylamine for nitrogenase assays.
Bravo, M; Eran, H; McKenna, CE; Zhang, FX, 1988
)
1.22
"The methylamine dehydrogenase is a basic protein (pI 8.8) and consists of light and heavy subunits (Mr 14100 and 43000; total Mr 112000)."( The role of blue copper proteins in the oxidation of methylamine by an obligate methylotroph.
Anthony, C; Lawton, SA, 1985
)
1

Effects

ExcerptReferenceRelevance
"Methylamine has previously been employed to selectively inactivate alpha 2-macroglobulin."( Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
Colman, RW; Gustafson, E; Idell, S; Schmaier, AH, 1984
)
0.99

Actions

Methylamine was found to inhibit the growth of several Bcc strains in a dose-dependent way. It also appeared to activate oocytes, and most of them developed by haploid parthenogenesis.

ExcerptReferenceRelevance
"Methylamine was found to inhibit the growth of several Bcc strains in a dose-dependent way."( Pseudoalteromonas haloplanktis produces methylamine, a volatile compound active against Burkholderia cepacia complex strains.
Apuzzo, GA; de Pascale, D; Fani, R; Fondi, M; Maida, I; Marino, G; Parrilli, E; Perrin, E; Sannino, F; Tedesco, P; Tutino, ML, 2017
)
1.44
"Methylamine seems to inhibit PC packaging by inhibiting trafficking of PC to lipid-rich light subcellular fractions."( Methylamine decreases trafficking and packaging of newly synthesized phosphatidylcholine in lamellar bodies in alveolar type II cells.
Chander, A; Higgins, S; Sen, N; Spitzer, AR; Wadsworth, S; Wu, AM, 1996
)
2.46
"Methylamine appeared to activate oocytes, and most of them developed by haploid parthenogenesis."( [Parthenogenetic development in response to the treatment of mouse oocytes with a weak alkali. Experiments with methylamine].
Dyban, AP; Noniashvili, EM,
)
1.06

Treatment

The methylamine-treated LDL showed particle size and net charge identical to fresh native LDL. Methylamine treatment at pH 11 followed by neutralization converts C3 into a modified state in which the molecule is optimally susceptible to cleavage by factor I in the presence of factor H.

ExcerptReferenceRelevance
"The methylamine-treated LDL showed particle size and net charge identical to fresh native LDL."( Methylamine-treated low density lipoproteins elicit different responses in HepG2 cells and macrophages.
Dashti, N; Koren, E; Lee, DM; Wilson, PR, 1993
)
2.21
"Methylamine-treated cells exhibited slow accumulation of SP-C16 and SP-C6, a persistence of SP-C21, and an absence of SP-C3.7 for the duration of the chase period."( Inhibition of cellular processing of surfactant protein C by drugs affecting intracellular pH gradients.
Beers, MF, 1996
)
1.02
"The methylamine-treated protein also had the Stokes radius of 7.9 nm."( Structural changes in alpha-2- and ovomacroglobulins studied by gel chromatography and electron microscopy.
Ikai, A; Nishigai, M; Osada, T, 1985
)
0.75
"Methylamine treatment at pH 11 followed by neutralization converts C3 into a modified state in which the molecule is optimally susceptible to cleavage by factor I in the presence of factor H."( Antigens of complement factor C3 involved in the interactions with factors I and H.
Nilsson, B; Nilsson, UR, 1986
)
0.99
"The methylamine-treated alpha-macroglobulin retained half the capacity to bind trypsin and its mobility in polyacrylamide gel under nondenaturing conditions remained virtually unchanged."( Isolation and characterization of alpha-macroglobulin from guinea pig plasma.
Sinohara, H; Suzuki, Y, 1986
)
0.75
"The methylamine-treated equine alpha 2M, with complete cleavage of the thiol ester bonds, still inhibited the activity of trypsin, though human alpha 2M lost its inhibitory activity by treatment with methylamine."( Electrophoretic and spectroscopic analyses of equine alpha 2-macroglobulin with cleavage of the thiol ester bonds by methylamine.
Funakoshi, T; Kubota, Y; Motoshima, A; Sera, M; Shoji, S; Ueki, H, 1988
)
0.97
"Methylamine treatment also released one thiol group per molecule."( Guinea pig plasma murinoglobulin. Purification and some properties.
Sinohara, H; Suzuki, Y, 1986
)
0.99
"Treatment with methylamine and ammonium chloride, inhibitors interfering with intracellular transport mechanisms, inhibits beta-secretase activity without influencing the physiological APP cleavage by alpha-secretase activity."( Inhibition of beta A4 production by specific modulation of beta-secretase activity.
Beyreuther, K; Czech, C; Dyrks, T; Reinsch, C; Turner, J; Urmoneit, B, 1995
)
0.63

Toxicity

nicotine can enhance SSAO/methylamine-mediated increase of formaldehyde and oxidative stress. This could in part contribute to the adverse effect of health associated with smoking.

ExcerptReferenceRelevance
" Although methylamines exert several toxic effects including inhibition of protein turnover and oocyte RNA synthesis, their reproductive toxicity has not been investigated."( Developmental toxicity of methylamines in mice.
Guest, I; Varma, DR, 1991
)
0.98
" We concluded that low doses of methylamine and dansylcadaverine have potent toxic effects on primary neuronal cultures."( Cytotoxic effects of monodansylcadaverine and methylamine in primary cultures of rat cerebellar neurons.
Gilad, GM; Gilad, VH, 1986
)
0.81
"Subcutaneous administration of the LD50 dose of methyl isocyanate (MIC) to rats induced severe hyperglycaemia, lactic acidosis and uraemia in rats."( Influence of methylamine and N,N'-dimethylurea, the hydrolysis products of methyl isocyanate, on its systemic toxicity.
Jeevaratnam, K; Sugendran, K; Vaidyanathan, CS,
)
0.5
" The findings support the idea that nicotine can enhance SSAO/methylamine-mediated increase of formaldehyde and oxidative stress and this could in part contribute the adverse effect of health associated with smoking."( Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity.
Yu, PH, 1998
)
0.84
" Our data show that AA and its aldehyde metabolite, acrolein, were the most toxic compounds to both cell types."( Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
Boor, PJ; Conklin, DJ; Langford, SD, 1998
)
0.3
" MA is toxic to cultured human umbilical vein and calf pulmonary artery endothelial cells."( Cultured rat vascular smooth muscle cells are resistant to methylamine toxicity: no correlation to semicarbazide-sensitive amine oxidase.
Boor, PJ; Langford, SD; Trent, MB, 2001
)
0.55
"3 g/kg/d) stimulated the production of methylamine and formaldehyde (as potential cytotoxic metabolites of creatine) in the urine of healthy humans, there was currently no definite clinical evidence about their adverse effects on the kidney function."( Potential Adverse Effects of Creatine Supplement on the Kidney in Athletes and Bodybuilders.
Davani-Davari, D; Ezzatzadegan-Jahromi, S; Karimzadeh, I; Sagheb, MM, 2018
)
0.75

Pharmacokinetics

ExcerptReferenceRelevance
" Clearance studies in mice show that the half-life of 125I-TGF-beta 1 in the circulation (1."( Interaction of transforming growth factor-beta 1 with alpha 2-macroglobulin. Role in transforming growth factor-beta 1 clearance.
O'Connor-McCourt, MD; Philip, A, 1991
)
0.28

Bioavailability

ExcerptReferenceRelevance
" The administration of an intragastric dose permitted the calculation of the systemic bioavailability of monomethylamine as 69 +/- 3%."( Deuterium isotope effect on the toxicokinetics of monomethylamine in the rat.
Heur, YH; Hrabie, JA; Keefer, LK; Mico, BA; Nims, RW; Ohannesian, L; Sheffels, PR; Streeter, AJ,
)
0.59

Dosage Studied

The dose-response curves of inhibition of mitogen-induced lymphocyte activation for chloroquine and methylamine are very steep. The curves are similar to those obtained with dimaprit and nordimaprit, but very different from the flat dose- response curves previously described for histamine. Further evidence was provided by ion pair HPLC analysis of urine from mice dosed with [14C]methyl-labeled N-methylformamide.

ExcerptRelevanceReference
" Further evidence that methylamine was a metabolite of N-methylformamide was provided by ion pair HPLC analysis of urine from mice dosed with [14C]methyl-labeled N-methylformamide."( The fate of N-methylformamide in mice. Routes of elimination and characterization of metabolites.
Gescher, A; Kestell, P; Slack, JA,
)
0.44
" The dose-response curves of inhibition of mitogen-induced lymphocyte activation for chloroquine and methylamine are very steep and are similar to the dose-response curves obtained with dimaprit and nordimaprit, but very different from the flat dose-response curves previously described for histamine."( A comparison of dimaprit, nordimaprit, methylamine and chloroquine as inhibitors of mitogen-induced lymphocyte activation.
Dale, MM; Ladd, R, 1984
)
0.75
" In contrast, MITC significantly decreased thymus weight and cellularity and changed peripheral white blood cell populations in a manner similar to that noted for an equimolar dosage of SMD."( Role of decomposition products in sodium methyldithiocarbamate-induced immunotoxicity.
Barnes, DB; Keil, DE; Padgett, EL; Pruett, SB, 1996
)
0.29
" These results suggest that MET is endowed with peculiar hypophagic effects at dosage levels that are not able to affect gross behaviour in mice."( Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels.
Banchelli, G; Galeotti, N; Ghelardini, C; Pirisino, R; Raimondi, L, 2001
)
1.75
" The slope of the dose-response curves for these two compounds and the partial hypophagic effect elicited by ammonia indicated a different action mechanism for these amines."( Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain Kv1.6 channel subtype.
Galeotti, N; Ghelardini, C; Pacini, A; Pirisino, R; Raimondi, L, 2004
)
1.77
" The removal efficiency was affected by initial NDMA concentration; higher NDMA dosing required higher ozone utilization."( Reinvestigation on the ozonation of N-nitrosodimethylamine: Influencing factors and degradation mechanism.
Li, Y; Lv, J; Song, Y, 2013
)
0.65
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
methylamines
primary aliphatic amine
one-carbon compoundAn organic molecular entity containing a single carbon atom (C1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (10)

PathwayProteinsCompounds
Tyrosine Metabolism1657
Alkaptonuria1657
Hawkinsinuria1657
Tyrosinemia Type I1657
Citalopram Action Pathway3724
Disulfiram Action Pathway2366
Tyrosinemia, Transient, of the Newborn1657
Dopamine beta-Hydroxylase Deficiency1657
Monoamine Oxidase-A Deficiency (MAO-A)1657
Citalopram Metabolism Pathway715

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gag-Pol polyproteinHIV-1 M:B_HXB2RIC50 (µMol)2.70000.00060.91418.3200AID1799907
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
viral life cycleGag-Pol polyproteinHIV-1 M:B_HXB2R
establishment of integrated proviral latencyGag-Pol polyproteinHIV-1 M:B_HXB2R
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
peptidase activityGag-Pol polyproteinHIV-1 M:B_HXB2R
integrase activityGag-Pol polyproteinHIV-1 M:B_HXB2R
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID1799907Inhibition Assay from Article 10.1021/cc9001026: \\Solid phase synthesis of novel pyrrolidinedione analogs as potent HIV-1 integrase inhibitors.\\
AID233502The pKa value was measured at N15 chemical shift changes due to protonation; nd= not determined1993Journal of medicinal chemistry, Nov-12, Volume: 36, Issue:23
Protonation of phosphoramide mustard and other phosphoramides.
AID158694In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum; Not active2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Evidences for the formation of bisbenzamidine-heme complexes in cell-free systems.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID1132810Dissociation constant, pKa of the compound1978Journal of medicinal chemistry, Jun, Volume: 21, Issue:6
Oxidative and cardiovascular studies on natural and synthetic catecholamines.
AID494749Inhibition of [3H]choline uptake at choline transporter 1 in mouse brain synaptosome2010Bioorganic & medicinal chemistry letters, Aug-15, Volume: 20, Issue:16
3-D-QSAR and docking studies on the neuronal choline transporter.
AID158696In vitro inhibitory concentration against chloroquine-sensitive Plasmodium falciparum; Not active2004Bioorganic & medicinal chemistry letters, Apr-05, Volume: 14, Issue:7
Evidences for the formation of bisbenzamidine-heme complexes in cell-free systems.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,242)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990442 (35.59)18.7374
1990's287 (23.11)18.2507
2000's254 (20.45)29.6817
2010's236 (19.00)24.3611
2020's23 (1.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 78.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index78.86 (24.57)
Research Supply Index7.16 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index143.25 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (78.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews21 (1.63%)6.00%
Case Studies3 (0.23%)4.05%
Observational0 (0.00%)0.25%
Other1,264 (98.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]